Genalyte Stock

Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.

Sign up today and learn more about Genalyte Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Genalyte Stock

Genalyte, Inc. is a life sciences company developing and commercializing innovative next-generation multiplexing technology. Genalyte has developed a new approach to immunodetection using silicon chip manufacturing methods. Its Maverick platform uses a technology called silicon photonics to directly measure protein binding between antibodies and antigens or hybridization of nucleic acids.

Funding History

March 2012$11.8M
August 2015$44.0M
November 2016$36.0M
January 2021$50.0M
March 2023$1.3M

Management

Chief Financial Officer

Ian Wisenberg

Board of Directors

Bradford C. Webb, PhD

Board Observer

Ted Hirose

Investor / Board Member

Saeid Akhtari

President & CSO, BaseHealth Analytics

Hossein Fakhrai-Rad

Board of Directors

Frank Litvack

Founder

Cary Gunn

Chief Medical Officer

Richard D. Hockett

President

Kevin Lo

Director

Joe Markee

Member, Board of Directors

Bradford C. Webb, PhD

Chief Financial Officer

Gerard van Hamel Platerink

Chief Executive Officer

Ashraf Hanna

Board of Directors

Franklin P. Antonio

VP Clinical Assay Development

Rufus Burlingame

Board Member

Andrew Conrad

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo